InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by GUSTAFSON MARK, Director. Director active across 1 company, notably Alzamend Neuro, Inc.. In total, 8 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €123k. Activity tracked since 13 September 2021. The latest transaction was filed on 31 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
20,000 shares@ US$1.21010.47% mcap17.8% of flowCommon StockSEC:0001214659-22-004803:0
50,000 shares0Common StockSEC:0001214659-22-003987:0
20,000 shares@ US$2.85431.09% mcap41.1% of flowCommon StockSEC:0001214659-21-013288:0
20,000 shares@ US$2.85431.09% mcap100.0% of flowCommon StockSEC:0001214659-21-013288
47,222 shares0Common StockSEC:0001214659-21-010559
47,222 shares0Common StockSEC:0001214659-21-010559:0
2,778 shares0Common StockSEC:0001214659-21-009539:0
2,778 shares0Common StockSEC:0001214659-21-009539
8 of 8 declarations
About GUSTAFSON MARK
Mark Gustafson serves as a Board Member at Alzamend Neuro, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into operations and market challenges. He also ensures that the company adheres to ethical and regulatory standards.
